We aimed to create mechanic optic nerve injury model in rats and investigate the neuroprotective effects of topical Coenzyme Q10 + Vitamin E (CoQ + Vit.E) molecules on retinal ganglion cells.
Methods:
Mechanic optic nerve injury model was created in the right eyes of rats (n = 12). Rats were divided into two groups: glaucoma model with sham treatment and topical CoQ + Vit.E treatment. Treatment was applied for 4 weeks. Glial fibrillary acidic protein, Brn-3a antibody, and anti-Iba1 were examined by immunohistochemistry. Glial fibrillary acidic protein, Bax, Bcl-xL, and Tfam protein expression were measured by Western blot analysis.
Results:
The number of Brn-3a-positive retinal ganglion cell was 15.0 ± 1.0 (min: 14, max: 16) in sham treatment group and 22.2 ± 4.8 (min: 18, max: 29) in topical CoQ10 + Vit.E treatment group. The protection of Brn-3a in CoQ10 + Vit.E was statistically significant (p < 0.05). Glial fibrillary acidic protein–positive astroglial counts were recorded as 11.7 ± 2.1 (min: 10, max: 14) in sham treatment and 2.5 ± 1.5 (min: 1, max: 4) in topical CoQ10 + Vit.E treatment group (p < 0.05). Topical CoQ10 + Vit.E treatment also decreased Iba1 expression in the retina of mechanic optic nerve injury groups. CoQ10 + Vit.E treatment prevented apoptotic cell death by increasing Bcl-xL protein expression. Also, CoQ10 + Vit.E preserved Tfam protein expression in the retina.
Conclusion:
This study has shown that in glaucoma treatment the neuron protecting effect of topical CoQ10 + Vit.E molecules can be valuable.
AgarwalRGuptaSKAgarwalP, et al. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol2009; 57(4): 257–266.
2.
TielschJMKatzJSinghK, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol1991; 134(10): 1102–1110, http://www.ncbi.nlm.nih.gov/pubmed/1746520 (accessed 28 October 2017).
JohnsonTVTomarevSI.Rodent models of glaucoma. Brain Res Bull2010; 81(2–3): 349–358.
7.
WhitmoreAVLibbyRTJohnSWM. Glaucoma: thinking in new ways—a rôle for autonomous axonal self-destruction and other compartmentalised processes?Prog Retin Eye Res2005; 24(6): 639–662.
8.
QuigleyHA.Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol1995; 23(2): 85–91, http://www.ncbi.nlm.nih.gov/pubmed/7546696 (accessed 20 May 2017).
9.
LeeDKimK-YShimMS, et al. Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury. Apoptosis2014; 19(4): 603–614.
10.
ChrysostomouVRezaniaFTrounceIA, et al. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol2013; 13(1): 12–15.
11.
DavisBMTianKPahlitzschM, et al. Topical coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion2017; 36: 114–123.
AhmedEDonovanTYujiaoL, et al. Mitochondrial targeted antioxidant in cerebral ischemia. J Neurol Neurosci2015; 6(2): 17, http://www.ncbi.nlm.nih.gov/pubmed/269-37332 (accessed 4 November 2017).
14.
KlongpanichapakSGovitrapongPSharmaSK, et al. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. Neurochem Res2006; 31(3): 303–311.
15.
PapucciLSchiavoneNWitortE, et al. Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem2003; 278(30): 28220–28228.
16.
FatoRBergaminiCLeoniS, et al. Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy. Acta Ophthalmol2009; 88(4): e150–e151.
17.
ItagakiSOchiaiAKobayashiM, et al. Interaction of coenzyme Q10 with the intestinal drug transporter P-glycoprotein. J Agric Food Chem2008; 56(16): 6923–6927.
18.
DavisSDavisBMRichensJL, et al. α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein. J Lipid Res2015; 56(8): 1543–1550.
19.
WuJHYWardNCIndrawanAP, et al. Effects of α-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem2007; 53(3): 511–519.
20.
NucciCTartaglioneRCerulliA, et al. Retinal damage caused by high intraocular pressure? Induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol2007; 82: 397–406.
21.
LulliMWitortEPapucciL, et al. Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo. J Radiat Res2012; 53(5): 695–703.
22.
XuSZhongMZhangL, et al. Overexpression of Tfam protects mitochondria against β-amyloid-induced oxidative damage in SH-SY5Y cells. FEBS J2009; 276(14): 3800–3809.
23.
TezelGChauhanBCLeBlancRP, et al. Immunohis-tochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest Ophthalmol Vis Sci2003; 44(7): 3025.
24.
FengD-FChenE-TLiX-Y, et al. Standardizing optic nerve crushes with an aneurysm clip. Neurol Res2010; 32(5): 476–481.
25.
RussoRCavaliereFRombolàL, et al. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res2008; 173: 575–582.
26.
SanoMErnestoCThomasRG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med1997; 336(17): 1216–1222.
27.
NakajimaYInokuchiYNishiM, et al. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res2008; 1226: 226–233.
28.
Salinas-NavarroMMayor-TorroglosaSJiménez-LópezM, et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vision Res2009; 49(1): 115–126.
29.
Nadal-NicolásFMJiménez-LópezMSobrado-CalvoP, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naïve and optic nerve–injured retinas. Invest Ophthalmol Vis Sci2009; 50(8): 3860.
30.
Nadal-NicolásFMJiménez-LópezMSalinas-NavarroM, et al. Whole number, distribution and co-expression of Brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS ONE2012; 7(11): e49830.
31.
LeeDShimMSKimK-Y, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophthalmol Vis Sci2014; 55(2): 993–1005.
32.
SurguchevaIWeismanADGoldbergJL, et al. γ-Synuclein as a marker of retinal ganglion cells. Mol Vis2008; 14: 1548–1548, https://www.ncbi.nlm.nih.gov/pubmed/18728752 (accessed 6 July 2017).
33.
SchuettaufFRejdakRWalskiM, et al. Retinal neurodegeneration in the DBA/2J mouse? A model for ocular hypertension. Acta Neuropathol2004; 107(4): 352–358.
34.
BoscoAInmanDMSteeleMR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci2008; 49(4): 1437.
35.
ParkSWKimK-YLindseyJD, et al. A selective inhibitor of Drp1, Mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina. Invest Ophthalmol Vis Sci2011; 52(5): 2837–2843.
36.
LeeDKimK-YNohYH, et al. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury. PLoS ONE2012; 7(10): e47098.
37.
BoiseLHGonzález-GarcíiaMPostemaCE, et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell1993; 74(4): 597–608.
38.
RongYDistelhorstCW.Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol2008; 70: 73–91.
39.
SchlesingerPHGrossAYinXM, et al. Comparison of the ion channel characteristics of proapoptotic Bax and antiapoptotic Bcl-2. Proc Natl Acad Sci USA1997; 94(21): 11357–11362.
40.
GalluzziLJozaNTasdemirE, et al. No death without life: vital functions of apoptotic effectors. Cell Death Differ2008; 15(7): 1113–1123.
41.
LarssonN-GWangJWilhelmssonH, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet1998; 18(3): 231–236.
42.
HokariMKurodaSKinugawaS, et al. Overexpression of mitochondrial transcription factor A (TFAM) ameliorates delayed neuronal death due to transient forebrain ischemia in mice. Neuropathology2010; 30(4): 401–407.
